Shoshana J Herzig1,2, Michael B Rothberg3, Jamey R Guess1, Jerry H Gurwitz4,5, Edward R Marcantonio1,2,6. 1. Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 2. Harvard Medical School, Boston, Massachusetts. 3. Center for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, Ohio. 4. Meyers Primary Care Institute, A Joint Endeavor of University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, Massachusetts. 5. University of Massachusetts Medical School, Worcester, Massachusetts. 6. Division of Gerontology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Abstract
BACKGROUND: Although antipsychotics are used for treatment of delirium/agitation in hospitalized patients, their scope of use has not been investigated in a large, multicenter cohort. OBJECTIVE: To determine rates of use and hospital variation in use of antipsychotics in nonpsychiatric admissions. DESIGN, SETTING, PATIENTS: Cohort study of adult, nonpsychiatric admissions to 300 US hospitals contributing data to the Premier database, from July 1, 2009 to June 30, 2010. MEASUREMENTS: Antipsychotic exposure defined using pharmacy charges. Potentially excessive dosing defined using guidelines for long-term care facilities. RESULTS: Our cohort included 2,695,081 admissions (median age, 63 years; 56% female). Antipsychotic exposure occurred in 160,773 (6%) admissions; 102,148 (64%) received atypical antipsychotics, 76,979 (48%) received typical, and 18,354 (11%) received both. Among exposed admissions, 47% received ≥1 potentially excessive daily dose. Among the variables we analyzed, the strongest predictors of antipsychotic receipt were delirium (relative risk [RR]: 2.93, 95% CI: 2.88-2.98) and dementia (RR: 2.78, 95% CI: 2.72-2.83). After adjustment for patient characteristics, patients admitted to hospitals in the highest antipsychotic prescribing quintile were more than twice as likely to be exposed compared to patients admitted to hospitals in the lowest prescribing quintile (RR: 2.56, 95% CI: 2.50-2.61). This relationship was similar across subgroups of admissions with delirium and dementia. CONCLUSIONS: Antipsychotic medication exposure is common in nonpsychiatric admissions to US hospitals. The observed variation in antipsychotic prescribing was not fully explained by measured patient characteristics, suggesting the possibility of differing hospital prescribing cultures. Additional research and guidelines are necessary to define appropriate use of these potentially harmful medications in the hospital setting. Journal of Hospital Medicine 2016;11:543-549.
BACKGROUND: Although antipsychotics are used for treatment of delirium/agitation in hospitalized patients, their scope of use has not been investigated in a large, multicenter cohort. OBJECTIVE: To determine rates of use and hospital variation in use of antipsychotics in nonpsychiatric admissions. DESIGN, SETTING, PATIENTS: Cohort study of adult, nonpsychiatric admissions to 300 US hospitals contributing data to the Premier database, from July 1, 2009 to June 30, 2010. MEASUREMENTS: Antipsychotic exposure defined using pharmacy charges. Potentially excessive dosing defined using guidelines for long-term care facilities. RESULTS: Our cohort included 2,695,081 admissions (median age, 63 years; 56% female). Antipsychotic exposure occurred in 160,773 (6%) admissions; 102,148 (64%) received atypical antipsychotics, 76,979 (48%) received typical, and 18,354 (11%) received both. Among exposed admissions, 47% received ≥1 potentially excessive daily dose. Among the variables we analyzed, the strongest predictors of antipsychotic receipt were delirium (relative risk [RR]: 2.93, 95% CI: 2.88-2.98) and dementia (RR: 2.78, 95% CI: 2.72-2.83). After adjustment for patient characteristics, patients admitted to hospitals in the highest antipsychotic prescribing quintile were more than twice as likely to be exposed compared to patients admitted to hospitals in the lowest prescribing quintile (RR: 2.56, 95% CI: 2.50-2.61). This relationship was similar across subgroups of admissions with delirium and dementia. CONCLUSIONS: Antipsychotic medication exposure is common in nonpsychiatric admissions to US hospitals. The observed variation in antipsychotic prescribing was not fully explained by measured patient characteristics, suggesting the possibility of differing hospital prescribing cultures. Additional research and guidelines are necessary to define appropriate use of these potentially harmful medications in the hospital setting. Journal of Hospital Medicine 2016;11:543-549.
Authors: Kah Poh Loh; Sheryl Ramdass; Jane L Garb; Maura J Brennan; Peter K Lindenauer; Tara Lagu Journal: J Hosp Med Date: 2014-10-24 Impact factor: 2.960
Authors: Melissa L P Mattison; Angela Catic; Roger B Davis; Daniele Olveczky; Julie Moran; Julius Yang; Mark Aronson; Mark Zeidel; Lewis Lipsitz; Edward R Marcantonio Journal: J Am Geriatr Soc Date: 2014-04-18 Impact factor: 5.562
Authors: Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke Journal: Crit Care Med Date: 2013-01 Impact factor: 7.598
Authors: Paula A Rochon; Therese A Stukel; Susan E Bronskill; Tara Gomes; Kathy Sykora; Walter P Wodchis; Michael Hillmer; Alexander Kopp; Jerry H Gurwitz; Geoffrey M Anderson Journal: Arch Intern Med Date: 2007-04-09
Authors: Dae Hyun Kim; Jung Lee; Caroline A Kim; Krista F Huybrechts; Brian T Bateman; Elisabetta Patorno; Edward R Marcantonio Journal: Pharmacoepidemiol Drug Saf Date: 2017-05-09 Impact factor: 2.890
Authors: Shoshana J Herzig; Mary T LaSalvia; Elliot Naidus; Michael B Rothberg; Wenxiao Zhou; Jerry H Gurwitz; Edward R Marcantonio Journal: J Am Geriatr Soc Date: 2017-11-02 Impact factor: 5.562
Authors: Dae Hyun Kim; Mufaddal Mahesri; Brian T Bateman; Krista F Huybrechts; Sharon K Inouye; Edward R Marcantonio; Shoshana J Herzig; E Wesley Ely; Margaret A Pisani; Raisa Levin; Jerry Avorn Journal: J Am Geriatr Soc Date: 2018-08-19 Impact factor: 5.562
Authors: Melissa R Riester; Parag Goyal; Lan Jiang; Sebhat Erqou; James L Rudolph; John E McGeary; Nicole M Rogus-Pulia; Caroline Madrigal; Lien Quach; Wen-Chih Wu; Andrew R Zullo Journal: J Gen Intern Med Date: 2022-01-03 Impact factor: 6.473
Authors: Matthew Basciotta; Wenxiao Zhou; Long Ngo; Michael Donnino; Edward R Marcantonio; Shoshana J Herzig Journal: J Am Geriatr Soc Date: 2019-11-19 Impact factor: 5.562
Authors: Matthew F Mart; Shawniqua Williams Roberson; Barbara Salas; Pratik P Pandharipande; E Wesley Ely Journal: Semin Respir Crit Care Med Date: 2020-08-03 Impact factor: 3.119